(0.26%) 5 113.43 points
(0.22%) 38 323 points
(0.27%) 15 972 points
(-1.50%) $82.59
(4.32%) $2.01
(0.04%) $2 348.20
(-0.30%) $27.45
(3.69%) $956.10
(-0.17%) $0.933
(-0.25%) $11.00
(-0.47%) $0.797
(1.76%) $93.49
1.21% $ 1.336
Live Chart Being Loaded With Signals
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation...
Stats | |
---|---|
Dzisiejszy wolumen | 33 277.00 |
Średni wolumen | 164 596 |
Kapitalizacja rynkowa | 73.62M |
EPS | $0 ( 2024-04-16 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.240 |
ATR14 | $0.0220 (1.65%) |
Connect Biopharma Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
REPL | 0.884 |
GGAL | 0.881 |
NWLI | 0.878 |
NYMTP | 0.878 |
JOUT | 0.874 |
ANPC | 0.873 |
SIOX | 0.872 |
OM | 0.872 |
AMYT | 0.871 |
HZNP | 0.87 |
10 Najbardziej negatywne korelacje | |
---|---|
LARK | -0.9 |
HMNF | -0.888 |
PCRX | -0.879 |
THTX | -0.868 |
USCB | -0.866 |
MARK | -0.865 |
SNPX | -0.864 |
SSB | -0.859 |
XFOR | -0.859 |
GOSS | -0.858 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Connect Biopharma Korelacja - Waluta/Towar
Connect Biopharma Finanse
Annual | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-14.50 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-14.50 |
Financial Reports:
No articles found.
Connect Biopharma
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation. The company was founded in 2012 and is headquartered in Taicang, China.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej